Does MERCAPTOPURINE Cause Second primary malignancy? 90 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 90 reports of Second primary malignancy have been filed in association with MERCAPTOPURINE (Mercaptopurine). This represents 0.8% of all adverse event reports for MERCAPTOPURINE.
90
Reports of Second primary malignancy with MERCAPTOPURINE
0.8%
of all MERCAPTOPURINE reports
30
Deaths
29
Hospitalizations
How Dangerous Is Second primary malignancy From MERCAPTOPURINE?
Of the 90 reports, 30 (33.3%) resulted in death, 29 (32.2%) required hospitalization, and 14 (15.6%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MERCAPTOPURINE. However, 90 reports have been filed with the FAERS database.
What Other Side Effects Does MERCAPTOPURINE Cause?
Febrile neutropenia (1,853)
Off label use (893)
Pyrexia (855)
Drug ineffective (721)
Vomiting (488)
Neutropenia (485)
Nausea (418)
Pneumonia (394)
Pancytopenia (392)
Sepsis (389)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which MERCAPTOPURINE Alternatives Have Lower Second primary malignancy Risk?
MERCAPTOPURINE vs MEROPENEM
MERCAPTOPURINE vs MEROPENEM ANHYDROUS
MERCAPTOPURINE vs MESALAMINE
MERCAPTOPURINE vs MESNA
MERCAPTOPURINE vs METAMIZOLE